Home > Publikationen > Publikationen & Wissenschaft

Publikationen & Wissenschaft

Publikationen & Wissenschaft, die aktuellsten 20 Einträge

Alle Einträge zeigen

  • 20. Mai 2020 - UROL CASE REP Rehder, P., Stuehmeier, J., Jelisejevas, L. A., Gulacsi, A., Horninger, W., and Pedrini, M. World record: Single AMS 800 artificial urinary sphincter functioning uninterrupted for 29 years in male paraplegic patient.
    Publikation auf PubMed

  • 13. Juli 2020 - EUR UROL FOCUS Tsaur, I., Heidegger, I., van den Bergh, R. C. N., Bektic, J., Borgmann, H., Foti, S., Hunting, J. C. B., Kretschmer, A., Ploussard, G., Tilki, D., Gandaglia, G., Dotzauer, R., and Party, E.-Y. P. C. W. Treatment of Metastasized Prostate Cancer Beyond Progression After Upfront Docetaxel-A Real-world Data Assessment.
    Publikation auf PubMed

  • 03. März 2020 - ONCOTARGET Dorris, E. R., O'Neill, A., Treacy, A., Klocker, H., Teltsh, O., Kay, E., and Watson, R. W. The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer
    Publikation auf PubMed

  • 10. April 2020 - EUR UROL Gandaglia, G., Martini, A., Ploussard, G., Fossati, N., Stabile, A., De Visschere, P., Borgmann, H., Heidegger, I., Steinkohl, F., Kretschmer, A., Marra, G., Mathieu, R., Surcel, C., Tilki, D., Tsaur, I., Valerio, M., Den Bergh, R. V., Ost, P., Gontero, P., Montorsi, F., Briganti, A., and Group, E.-Y. P. C. W. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.
    Publikation auf PubMed

  • 09. April 2020 - FRONT MOL BIOSCI Drapela, S., Bouchal, J., Jolly, M. K., Culig, Z., and Soucek, K. ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance.
    Publikation auf PubMed

  • 20. März 2020 - NAT COMMUN Schopf, B., Weissensteiner, H., Schafer, G., Fazzini, F., Charoentong, P., Naschberger, A., Rupp, B., Fendt, L., Bukur, V., Giese, I., Sorn, P., Sant'Anna-Silva, A. C., Iglesias-Gonzalez, J., Sahin, U., Kronenberg, F., Gnaiger, E., and Klocker, H. OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation
    Publikation auf PubMed

  • 03. März 2020 - ONCOTARGET Dorris, E. R., O'Neill, A., Treacy, A., Klocker, H., Teltsh, O., Kay, E., and Watson, R. W. The transcription factor CUX1 negatively regulates invasion in castrate resistant prostate cancer.
    Publikation auf PubMed

  • 12. März 2020 - BJUI COMPASS Klocker, H., Golding, B., Weber, S., Steiner, E., Tennstedt, P., Keller, T., Schiess, R., Gillessen, S., Horninger, W., and Steuber, T. Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer. https://onlinelibrary.wiley.com/doi/abs/10.1002/bco2.8

  • 16. Februar 2020 - CANCERS (BASEL) Eigentler, A., Tymoszuk, P., Zwick, J., Schmitz, A. A., Pircher, A., Kocher, F., Schlicker, A., Lesche, R., Schafer, G., Theurl, I., Klocker, H., and Heidegger, I. The Impact of Cand1 in Prostate Cancer.
    Publikation auf PubMed

  • 06. Februar 2020 - ANN TRANSL MED Pichler, R. and Schmidinger, M. Can immune biomarkers predict benefit from targeted agents in metastatic renal cell carcinoma?
    Publikation auf PubMed

  • 26. Jänner 2020 - CELL COMMUN SIGNAL Neuwirt, H., Bouchal, J., Kharaishvili, G., Ploner, C., Johrer, K., Pitterl, F., Weber, A., Klocker, H., and Eder, I. E. Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.
    Publikation auf PubMed

  • 25. Jänner 2020 CANCER CYTOPATHOL Trenti Pycha et al Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer
    Publikation auf PubMed

  • 19. Jänner 2020 UROL ONCOL Heidegger, I., Brandt, M. P., and Heck, M. M. Treatment of non-metastatic castration resistant prostate cancer in 2020: What is the best?
    Publikation auf PubMed

  • 18. Jänner 2020 - ENDOCR RELAT CANCER Gruber, M., Ferrone, L., Puhr, M., Santer, F. R., Furlan, T., Eder, I. E., Sampson, N., Schafer, G., Handle, F., and Culig, Z. p300 is up-regulated by docetaxel and is a target in chemoresistant prostate cancer.
    Publikation auf PubMed

  • 27. Dezember 2019 - GEBURTSHILFE FRAUENHEILKD Toth, B., Baston-Bust, D. M., Behre, H. M., Bielfeld, A., Bohlmann, M., Buhling, K., Dittrich, R., Goeckenjan, M., Hancke, K., Kliesch, S., Kohn, F. M., Krussel, J., Kuon, R., Liebenthron, J., Nawroth, F., Nordhoff, V., Pinggera, G. M., Rogenhofer, N., Rudnik-Schoneborn, S., Schuppe, H. C., Schuring, A., Seifert-Klauss, V., Strowitzki, T., Tuttelmann, F., Vomstein, K., Wildt, L., Wischmann, T., Wunder, D., and Zschocke, J. Diagnosis and Treatment Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 2, Hemostaseology, Andrology, Genetics and History of Malignant Disease.
    Publikation auf PubMed

  • 27. Dezember 2019 - GEBURTSHILFE FRAUENHEILKD Toth, B., Baston-Bust, D. M., Behre, H. M., Bielfeld, A., Bohlmann, M., Buhling, K., Dittrich, R., Goeckenjan, M., Hancke, K., Kliesch, S., Kohn, F. M., Krussel, J., Kuon, R., Liebenthron, J., Nawroth, F., Nordhoff, V., Pinggera, G. M., Rogenhofer, N., Rudnik-Schoneborn, S., Schuppe, H. C., Schuring, A., Seifert-Klauss, V., Strowitzki, T., Tuttelmann, F., Vomstein, K., Wildt, L., Wischmann, T., Wunder, D., and Zschocke, J. Diagnosis and Therapy Before Assisted Reproductive Treatments. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Register Number 015-085, February 2019) - Part 1, Basic Assessment of the Woman.
    Publikation auf PubMed

  • 18. Dezember 2019 - AM J PATHOL Pichler, R., Lindner, A. K., Comperat, E., Obrist, P., Schafer, G., Todenhofer, T., Horninger, W., Culig, Z., and Untergasser, G. Amplification of 7p12 Is Associated with Pathologic Nonresponse to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
    Publikation auf PubMed

  • 14. Dezember 2019 - PROSTATE Gruber, M., Handle, F., and Culig, Z. The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells.
    Publikation auf PubMed

  • 13. Dezember 2019 - EUR UROL Radmayr, C. Re: Cancer Screening in the Pediatric Cancer Patient: A Focus on Genitourinary Malignancies, and Why Does a Urologist Need to Know About This?
    Publikation auf PubMed

  • 04. Dezember 2019 - NEUROUROL URODYN Stein, R., Bogaert, G., Dogan, H. S., Hoen, L., Kocvara, R., Nijman, R. J. M., Quaedackers, J., Rawashdeh, Y. F., Silay, M. S., Tekgul, S., and Radmayr, C. EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management.
    Publikation auf PubMed

Universitätsklinik für Urologie - Labor | Abt. für Experimentelle Urologie | Anichstraße 35, 6020 Innsbruck
Tel.: +43 512 504 24874 | Fax.: +43 512 504 24817 | Email: lki.ur.labor@tirol-kliniken.at